Institute of Fundamental Technological Research
Polish Academy of Sciences

Partners

Anna Cmoch

Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)

Recent publications
1.  Bielak-Żmijewska A., Wnuk M., Przybylska D., Grabowska W., Lewinska A., Alster O., Korwek Z., Cmoch A., Myszka A., Pikula S., Mosieniak G., Sikora E., A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta, BIOGERONTOLOGY, ISSN: 1389-5729, DOI: 10.1007/s10522-013-9477-9, Vol.15, pp.47-64, 2014

Abstract:
Senescence of vascular smooth muscle cells (VSMCs) contributes to aging as well as age-related diseases of the cardiovascular system. Senescent VSMCs have been shown to be present in atherosclerotic plaques. Both replicative (RS) and stress-induced premature senescence (SIPS) accompany cardiovascular diseases. We aimed to establish the signature of RS and SIPS of VSMCs, induced by a common anticancer drug, doxorubicin, and to discover the so far undisclosed features of senescent cells that are potentially harmful to the organism. Most of the senescence hallmarks were common for both RS and SIPS; however, some differences were observed. 32 % of doxorubicin-treated cells were arrested in the G2/M phase of the cell cycle, while 73 % of replicatively senescing cells were arrested in the G1 phase. Moreover, on the basis of alkaline phosphatase activity measurements, we show that a 7-day treatment with doxorubicin (dox), does not cause precocious cell calcification, which is a characteristic feature of RS. We did not observe calcification even though after 7 days of dox-treatment many other markers characteristic for senescent cells were present. It can suggest that dox-induced SIPS does not accelerate the mineralization of vessels. We consider that detailed characterization of the two types of cellular senescence can be useful in in vitro studies of potential anti-aging factors.

Keywords:
Senescence, VSMCs, Doxorubicin, Aging, Cardiovascular diseases, Calcification

Affiliations:
Bielak-Żmijewska A. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Wnuk M. - other affiliation
Przybylska D. - other affiliation
Grabowska W. - other affiliation
Lewinska A. - other affiliation
Alster O. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Korwek Z. - other affiliation
Cmoch A. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Myszka A. - other affiliation
Pikula S. - other affiliation
Mosieniak G. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Sikora E. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)

Category A Plus

IPPT PAN

logo ippt            Pawińskiego 5B, 02-106 Warsaw
  +48 22 826 12 81 (central)
  +48 22 826 98 15
 

Find Us

mapka
© Institute of Fundamental Technological Research Polish Academy of Sciences 2024